Search for: "United States v. LaRoche" Results 21 - 40 of 42
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
7 Nov 2014, 5:52 am
Hoffman-LaRoche, Inc., 949 F.2d 806, 814 (5th Cir. 1992) (applying Mississippi law), which you can find later in this post.What happens when a heeding presumption is imposed concerning a risk warning? [read post]
17 Oct 2008, 1:32 pm
Proposed EU information laws on prescription drugs (IPmed) Iceland: Supplementary Protection Certificates (SPCs) in Iceland (The SPC blog) India: Roche implements 'mass serialisation' anti-counterfeiting technology (Spicy IP) Indonesia: Patent application on oil palm hybrids (navigating the patent maze) United States: New PMCA research: State legislative proposals restricting access to generic medicines would increase cost $29 billion over 10 years… [read post]
25 Mar 2010, 2:41 am by Kevin LaCroix
Most recently in the Court’s 2004 decision in Hoffman-LaRoche Ltd. v. [read post]
24 May 2007, 10:40 am
Hoffman-LaRoche, Inc., 949 F.2d 806, 816 (5th Cir. 1992) (applying Mississippi law). [read post]
6 Jan 2010, 6:00 am by Beck, et al.
Hoffman-LaRoche, 189 N.J. 615 (2007) (our prior post here), and International Union of Operating Engineers v. [read post]
18 Jul 2014, 11:55 am
June. 13, 2013), holding essentially that, since those meanies on the United States Supreme Court aren’t letting plaintiffs sue generic manufacturers, we’ll change Alabama common law and let them sue someone else. [read post]
5 Apr 2013, 1:01 pm by Bexis
Hoffmann-LaRoche Inc., 2013 WL 1191899 (E.D.N.C. [read post]
9 Jan 2014, 1:37 pm
Md. 2012) (same); New York State Pesticide Coalition, Inc. v. [read post]
23 May 2011, 4:00 am by Steve McConnell
But it doesn't matter because it doesn't look like there have been more than two cases of SJS-from-cephalexin in the United States from 1992 to 2008. [read post]
4 Nov 2021, 5:37 am by Eugene Volokh
And litigation of course deploys the coercive power of the state, even as it also accomplishes private goals. [read post]
15 May 2010, 2:22 pm
"'[T]he types of conduct which can form a basis for finding a case exceptional [include] . . . inequitable conduct before the P.T.O., [and] misconduct during litigation.'" Hoffman-LaRoche, Inc. v. [read post]
22 Dec 2011, 11:59 am by Bexis
  All this in a state – Illinois – where the highest court forbids FDCA-based common-law causes of action (see Martin v. [read post]
2 May 2008, 7:00 am
: (Patent Baristas), US: How to avoid a permanent injunction: the lessons of Amgen v Hoffman-LaRoche: (Patent Docs), US: Jarvik Heart’s PTE request based on PMA shell/module submission dates flatlines; ruling on initiation of PTE ‘review period’ mirrors FDA policy for ‘fast track’ products: (FDA Law Blog) Pharma & Biotech - Products Kytril (Granisetron) – Exclusivity ‘parking’… [read post]
11 Jul 2008, 4:30 am
You can separately subscribe to the IP Thinktank Global week in Review at the Subscribe page: [duncanbucknell.com]   Highlights this week included: ACTA continues to be discussed and debated: (Michael Geist), (Intellectual Property Watch), (Public Knowledge),  (Techdirt), (Managing Intellectual Property), (Public Knowledge), (Public Knowledge), (Public Knowledge), Apotex challenge to Acular LS patent barred by res judicata: Roche Palo Alto & Allergan v Apotex:… [read post]